Quick Answer
RxSight, Inc. reported Gross Profit of $103.01 million for the year ending 2025.
- RxSight, Inc. showed an increase of +4.1% in Gross Profit from 2024 to 2025.
- This data is from RxSight, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: -$474.0 thousand | Q3 2020: $720.0 thousand | Q1 2021: $1.12 million | Q2 2021: -$812.0 thousand | Q3 2021: $1.34 million | Q1 2022: $3.76 million | Q2 2022: $4.79 million | Q3 2022: $5.36 million | Q1 2023: $10.37 million | Q2 2023: $12.02 million | Q3 2023: $13.73 million | Q1 2024: $20.69 million | Q2 2024: $24.25 million | Q3 2024: $25.22 million | Q1 2025: $28.33 million | Q2 2025: $25.19 million | Q3 2025: $24.23 million.
- Over the full 6 years of available data (2020 to 2025), RxSight, Inc.'s Gross Profit has grown by 5,941.6%.
- Historical annual values: Fiscal year 2025: $103.01 million | Fiscal year 2024: $98.94 million | Fiscal year 2023: $53.77 million | Fiscal year 2022: $21.33 million | Fiscal year 2021: $4.52 million | Fiscal year 2020: $1.71 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: